What is CeriBell, Inc (CBLL) stock price today?

CeriBell, Inc (CBLL) currently trades at $20.16 per share. The stock has a market capitalization of $802.14M and a P/E ratio of —x.

Is CBLL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CeriBell, Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is CeriBell, Inc's revenue and earnings?

CeriBell, Inc has trailing twelve-month (TTM) revenue of $89.06M with profit margins of -60.00%. Earnings per share (EPS) is $-1.46.

CBLL

CeriBell, Inc

NASDAQ: CBLL · HEALTHCARE · MEDICAL DEVICES

$20.16

+4.73% today

Updated 2026-04-30

Market cap

$802.14M

P/E ratio

—

P/S ratio

9.01x

EPS (TTM)

$-1.46

Dividend yield

—

52W range

$11 – $24

Volume

0.3M

Market cap

$802.14M

P/E ratio

—

P/S ratio

9.01x

EPS (TTM)

$-1.46

Dividend yield

—

52W range

$11 – $24

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$27.57

+36.76%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 33.70% QoQ

Risks

- Thin margins at -60.00%

- Negative free cash flow $-10.95M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$25.92M	$45.23M	$65.44M	$89.06M	$89.06M
Net income	$-37.16M	$-29.46M	$-40.45M	$-53.41M	$-13.53M
EPS	—	—	—	—	$-1.46
Free cash flow	$-32.52M	$-30.14M	$-36.38M	$-41.58M	$-10.95M
Profit margin	-143.37%	-65.15%	-61.82%	-59.97%	-60.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CBLL	$802.14M	28	8.0	2.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CeriBell, Inc trades at $20.16. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $89.06M. with profit margins at -60.00%.

Frequently asked questions

What is CeriBell, Inc's stock price?

CeriBell, Inc (CBLL) trades at $20.16.

Is CeriBell, Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of CeriBell, Inc (CBLL)?

The analyst target price is $27.57, representing +36.8% upside from the current price of $20.16.

What is CeriBell, Inc's revenue?

TTM revenue is $89.06M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio9.01x

ROE-30.80%

Beta—

50D MA$19.15

200D MA$16.55

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week-1.23%

1 month+13.48%

3 months+1.81%

YTD-5.15%

1 year—

3 years—

5 years—

Compare

CBLL vs LLY →CBLL vs JNJ →CBLL vs ABBV →Stock screener →